TL;DR
A proposed FDA rule would replace the voluntary approach to GRAS ingredient notifications with a requirement that companies notify the agency before using an ingredient. The change could give regulators and the public more information, but it would not require FDA approval before products reach stores, and the agency’s review capacity remains a concern.
A proposed FDA rule would require food companies to notify the agency before using ingredients they classify as Generally Recognized as Safe (GRAS), replacing a system that has allowed companies to make some safety determinations without informing federal regulators. The proposal could make ingredient information more visible to the FDA and public, but it would not require the agency to approve an ingredient before it is used.
Get kitchen staples and gadgets delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
GRAS was created by Congress in 1958 to exempt familiar substances, including salt, vinegar and baking soda, from the formal review process for new food additives. Under the approach described in the report, companies can determine that a substance is GRAS using scientific evidence and expert review. They may notify the FDA, but the current notification process is voluntary, so some companies can begin using ingredients without alerting the agency.
The proposed rule would make notification mandatory before use. That would give the FDA a record of ingredients companies intend to use and could make information available to researchers and the public. The report says a searchable government record could also help medical professionals investigating possible food-related reactions, although it does not establish that the proposed system would itself identify the cause of any particular health problem.
Mandatory notification would not equal premarket approval. According to the report, companies could begin selling products while a notification is being reviewed. FDA review could take as long as a year, with possible extensions, and a later determination that evidence was inadequate could expose a company to recalls or legal claims. The report also estimates that more than 1,000 ingredients already in use could require retroactive paperwork; it does not provide a detailed timeline or accounting for that estimate.
More Ingredient Data, Not Prior Approval
The proposed change could reduce the information gap created when companies use ingredients without notifying federal regulators. A required filing would give the FDA a clearer record of substances entering the food supply and could help researchers and health professionals learn what ingredients are present when they investigate potential adverse reactions. Public access to notifications could also make company safety reasoning easier to scrutinize.
But the practical effect would depend on what the FDA does with those filings. Notification alone does not establish safety, and a filing requirement would not prevent a product from reaching stores during review. If the agency lacks staff or time to assess submissions, a public database could create an impression of oversight without a timely government evaluation. The proposal would change disclosure obligations, while leaving a key question—how quickly and consistently FDA can review the evidence—unanswered.
The requirements could also affect companies differently. The report says retroactive filings for a large number of existing ingredients may weigh more heavily on smaller manufacturers. Companies could face new costs and possible legal exposure once their notifications become public. Those effects are possibilities described in the report, not confirmed outcomes under an implemented rule.
Popular right now
Dyson V15 Detect Cordless Vacuum
KitchenAid 3-Piece Pasta Roller and Cutter Set for Stand Mixers
Bose QuietComfort Wireless Headphones – Twilight Blue (Limited Edition)
As an affiliate, we earn on qualifying purchases.
How the GRAS Exemption Developed
Congress established GRAS in 1958 as a way to distinguish substances with a recognized history of safe use from genuinely new food additives requiring formal review. The exemption was intended to avoid imposing costly testing on ordinary ingredients such as table salt, vinegar and baking soda.
The approach described by Food Safety News allows companies to rely on their own safety assessments, including reviews by scientists they select, and to use a substance without submitting a notice to the FDA. Consumer advocacy organizations cited in the report say that this has left regulators and the public with an incomplete record of ingredients used in food. The source does not name those organizations or provide a count of substances used without notification.
The proposed rule is presented as a move away from this voluntary, company-led notification system. It would require advance notice, but the source does not provide the full proposed rule text, its publication date, or details of any public-comment period.
““Moving away from a purely voluntary system is a genuine improvement.””
— Cynthia Joseph, Food Safety News report author
Review Capacity and Rule Details
The source describes a proposed rule, but does not specify its formal status, publication date, deadline for public comments, or when a final rule might take effect. It is also unclear from the material what information companies would have to submit, how the FDA would prioritize filings, or what enforcement measures would apply to companies that fail to notify the agency.
The report says reviews could take up to a year, with extensions, but does not identify a firm review deadline or explain what would happen to a filing left pending. It also does not establish how many FDA staff or resources would be available. The estimate that more than 1,000 existing ingredients may need retroactive paperwork is not accompanied by a list or a schedule.
Even if the notification requirement takes effect, questions about combined exposure to multiple additives would remain, according to the report. States could also continue to set their own additive bans or warning-label requirements. The proposal’s effect on product safety, litigation, business costs and differences among state rules cannot yet be determined from the available information.
FDA Rulemaking and Implementation
The next steps depend on the FDA’s rulemaking process. The agency would need to finalize the proposed requirement and set out the filing, review and compliance procedures. The source material does not state when those steps are expected or whether the FDA has issued a final rule.
If the rule is finalized, companies would need to comply with the notification requirement and address any retroactive submissions covered by the final policy. The FDA’s staffing, review pace and response to incomplete or unsupported filings will be key indicators of whether required disclosure leads to substantive oversight. Until those details are available, the confirmed development is a proposal for mandatory notification, not a new system of FDA premarket approval.
Key Questions
What does GRAS mean?
GRAS stands for Generally Recognized as Safe. The category was created in 1958 for substances considered safe based on recognized knowledge or experience, allowing them to be treated differently from new food additives requiring formal review.
What would the proposed FDA rule change?
It would require companies to notify the FDA before using a GRAS ingredient, replacing the voluntary notification approach described in the report. The source does not provide the proposed rule’s full filing requirements or implementation schedule.
Would the FDA have to approve ingredients before they are sold?
No. The report says mandatory notification is not the same as premarket approval. Companies could begin using an ingredient while a notification is under review.
How long might FDA reviews take?
The report says reviews could take up to a year, with extensions. It does not identify a firm deadline or explain how the FDA would manage filings that remain under review.
What is still unknown about the proposal?
The source does not specify the rule’s formal status, final requirements, expected start date, FDA staffing, or enforcement plan. It also does not say how the agency would handle the estimated more than 1,000 ingredients already on the market that may require retroactive paperwork.
Source: foodsafetynews.com
